WeightWatchers soars after Sequence acquisition
4.9 (609) · € 21.50 · En Stock
WeightWatchers soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
WeightWatchers (WW) Stock Falls After Largest Shareholder Artal
WeightWatchers To Acquire Chronic Weight Management Digital Health
WeightWatchers enters the Rx business for obesity - Insider
Weight Watchers International soars as it confirms expansion into
Cytokinetics Said to Weigh Options Amid Takeover Interest - Bloomberg
Weight Watchers enters telehealth prescription drug space with
Weight Watches Parent's Stock Soars Again On Obesity-Drug, Goldman
Weight Watchers Reshapes Itself with a Game-Changer Acquisition
WeightWatchers to buy Sequence telehealth, enter obesity drug
New U.S. childhood obesity guidelines recommend surgery, drugs
WeightWatchers Is Acquiring Sequence for $106 Million
FDA seizes 'thousands of units' of fake Ozempic as demand soars
WeightWatchers to buy Sequence, enter weight loss drug market
